"IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas," Graefe's Archive for Clinical and Experimental Ophthalmology (Vol: 250, Issue: 10, Page 1541-1548) - 2012
"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone," Journal of Clinical Oncology (Vol: 30, Issue: 28, Page 3452-3459) - 2012
"A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma," Blood (Vol: 120, Issue: 11, Page 2290-2296) - 2012
"Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone," Haematologica (Vol: 97, Issue: 6, Page 937-942) - 2012
"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis," Blood (Vol: 119, Issue: 21, Page 4939-4948) - 2012
"RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia," Leukemia and Lymphoma (Vol: 53, Issue: 5, Page 999-1002) - 2012
"BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab," Clinical Cancer Research (Vol: 17, Issue: 24, Page 7785-7795) - 2011
"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype," Blood (Vol: 118, Issue: 20, Page 5550-5558) - 2011
"High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy," Haematologica (Vol: 96, Issue: 7, Page 996-1001) - 2011
"Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues," Clinical Cancer Research (Vol: 17, Issue: 11, Page 3727-3732) - 2011
"Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms," American Journal of Clinical Pathology (Vol: 135, Issue: 5, Page 709-719) - 2011
"Oncogenically active MYD88 mutations in human lymphoma," Nature (Vol: 470, Issue: 7332, Page 115-121) - 2011
"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab," Journal of Clinical Oncology (Vol: 29, Issue: 2, Page 200-207) - 2011
"The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab," American Journal of Clinical Pathology (Vol: 135, Issue: 1, Page 54-61) - 2011
"Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides," American Journal of Clinical Pathology (Vol: 134, Issue: 5, Page 739-748) - 2010
"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling," Blood (Vol: 116, Issue: 6, Page 953-961) - 2010
"Immunophenotypic variations of Burkitt lymphoma," American Journal of Clinical Pathology (Vol: 134, Issue: 1, Page 127-138) - 2010
"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma," New England Journal of Medicine (Vol: 362, Issue: 10, Page 875-885) - 2010
"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma," Nature (Vol: 463, Issue: 7277, Page 88-92) - 2010
"Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV," Leukemia and Lymphoma (Vol: 50, Issue: 11, Page 1875-1878) - 2009
